Here students in global health can analyze news articles relevant to concepts we discuss in class. Please share insight, ask questions, and draw attention to issues that are most relevant to your journey in global health!
Sunday, May 8, 2011
The Value of Meditation
Globalization of Disease
Thursday, May 5, 2011
Cholera Surge in Haiti

Fewer Mammograms Being Done
Wednesday, May 4, 2011
Asthma Numbers Rise in US
The levels of asthma in the country have now reached 1 in 10 for children and 1 in 12 for adults according to the most recent figures. Looking at the prevalence of asthma in populations across the country, figures have increased since 2003 for all racial groups as well as gender and age groups. This suggests that the problem of asthma is not just affecting individuals with a particular lifestyle, but everyone.
One of the most alarming parts of this report is that the increased numbers of people with asthma occurred at the same time as a general decrease in the number of smokers in the country. Before this information, many scientists assumed that smoking was the leading cause of asthma increases. What this suggests is that there are environmental triggers causing the disease. These could include environmental pollutants, traffic exhaust, plastics, and use of pesticides.
This has a major tie-in to the topic of environmental health that we looked at in class. When people don't live in a healthy environment, their overall health deteriorates, which also causes a rise in the cost of treating the general population. The article mentioned that people should be better informed about how to treat their asthma, but I consider this to be a very superficial solution. If asthma levels are universally rising, it seems like the root cause of this increase is something that would be work investigating and solving.
Burkina Faso Tests Malaria Vaccine
Malaria is a major health concern for Burkina Faso. On average, each Burkinbe child under age five will fall ill with Malaria twice a year. On April 29th, Burkina Faso's national malaria research center began vaccinating volunteer subjects. This clinical trial is part of a multi-national program funded by the European an Developing Countries Clinical Trials Partnership (EDCTP). Burkina Faso is the second site in Africa to begin testing the vaccine on human subjects. Clinical testing of the vaccine has been underway in Gabon since November of last year. The next two nations to carry out clinical trials of GMZ2 are Ghana and Uganda.
If effective, vaccinations against malaria could save a significant number of disability-adjusted life years globally. Do you think plasmodium falciparum will mutate too rapidly for the vaccine to be benificial in the long term? After having gained insight from our mock World Health Assembly session on Polio, can you think of any difficulties that might arise if health authorities decide to try to vaccinate all populations at risk for Malaria?
Tuesday, May 3, 2011
Hormones Create Hope
As we have talked about during many class periods this semester, premature birth is the leading cause of death and illness among new-borns. An article I recently read in the New York Times shed some positive light on this otherwise saddening topic. According to a recent study, a daily dose of hormone gel reduced premature births by nearly half among women at particularly high risk. If proven accurate, this study could turn into an extremely effective world-wide health intervention.
This new treatment is a hormone treatment, taken by the woman daily during the second half of a pregnancy. This treatment is relatively simple yet it could have a great impact on the birth of several babies worldwide. It is estimated that 2% of the nation’s 500,000 annual preterm births could be prevented. Also, it is predicted that screening all women and determining which are at highest risk for delivering pre-term could save the nation’s health system 12 million dollars a year. The treatment is also relatively easy for women to administer to themselves.
As I read this article, I was encouraged by the potential this treatment has for mothers and their children worldwide. However, it left me questioning how this drug would be administered due to the social, culture and financial barriers that could get in the way. It frustrates me that these barriers could prevent the use of a treatment that could significantly reduce the leading cause of infant mortality. I strongly believe that if a distribution program was set up to address these barriers, this hormone treatment could really make a difference. It is inexpensive, relatively easy to use, and overall the perfect candidate for poorer, less educated countries (the countries that need it most). I think the major problem will be the follow up—making sure that the women are taking the hormones every day for the most effect. This could certainly cause any program to lose effectiveness.